首页|心脏彩超联合心电图对冠心病伴心力衰竭病情程度的诊断价值分析

心脏彩超联合心电图对冠心病伴心力衰竭病情程度的诊断价值分析

扫码查看
目的 分析临床诊断冠心病伴心力衰竭患者病情程度期间予以心脏彩超联合心电图的诊断价值。方法 120 例冠心病伴心力衰竭患者,均进行心脏彩超、心电图检测。分析患者纽约心脏病协会(NYHA)心功能分级情况,对比不同病情程度患者心脏彩超指标、心电图指标及不同检测方法的冠心病伴心力衰竭诊断准确率。结果 120 例患者中,NYHA心功能分级Ⅱ级患者例数为 45 例、占比37。50%,Ⅲ级患者例数为 42 例、占比 35。00%,Ⅳ级患者例数为 33 例、占比 27。50%。NYHA心功能分级Ⅳ级患者左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)、左心房内径(LA)均高于Ⅲ级及Ⅱ级患者,左心室射血分数(LVEF)、二尖瓣舒张早期与晚期血流峰值速度比值(E/A)均低于Ⅲ级及Ⅱ级患者,具备统计学差异(P<0。05);且NYHA心功能分级Ⅲ级患者LVESD、LVEDD、LA高于Ⅱ级患者,LVEF、E/A均低于Ⅱ级患者,具备统计学差异(P<0。05)。NYHA心功能分级Ⅳ级、Ⅲ级、Ⅱ级患者的QRS电压分别为(12。02±0。89)、(13。34±0。71)、(14。87±0。65)mV,QRS时限分别为(133。75±15。67)、(125。47±17。54)、(112。86±15。54)ms,QTc间期分别为(472。65±23。65)、(441。69±22。87)、(424。66±20。54)ms。NYHA心功能分级Ⅳ级、Ⅲ级患者QRS电压低于Ⅱ级患者,QRS时限、QTc间期长于Ⅱ级患者,具备统计学差异(P<0。05);且心功能Ⅳ级患者QRS电压低于Ⅲ级患者,QRS时限、QTc间期长于Ⅲ级患者,具备统计学差异(P<0。05)。心脏彩超+心电图联合检测诊断准确率(99。17%)较单独使用心脏彩超(94。17%)及心电图(91。67%)更高,具备统计学差异(P<0。05)。结论 临床在诊断冠心病伴心力衰竭患者病情程度期间,使用心脏彩超联合心电图的诊断价值更高,比单一检测更准确,能够及时掌握病症发展情况,结合检测结果予以对应措施进行干预,挽救患者生命健康,值得临床广泛使用。
Analysis of diagnostic value of echocardiography combined with electrocardiogram on the severity of coronary heart disease with heart failure
Objective To analyze the diagnostic value of echocardiography combined with electrocardiogram on the severity of coronary heart disease with heart failure.Methods A total of 120 patients with coronary heart disease and heart failure were included in this study.All the patients were detected by echocardiography and electrocardiogram.The New York Heart Association(NYHA)cardiac function grading was analyzed.The echocardiography indexes and electrocardiogram indexes of patients with different severity of disease were compared,as well as the diagnostic accuracy of different detection methods for coronary heart disease with heart failure.Results Among the 120 patients,45 patients were in NYHA cardiac function grade Ⅱ,accounting for 37.50%,42 patients in grade Ⅲ,accounting for 35.00%,and 33 patients in grade Ⅳ,accounting for 27.50%.In NYHA grade Ⅳ patients,the left ventricular end-systolic diameter(LVESD),left ventricular end-diastolic diameter(LVEDD),and left atrium(LA)were higher than those in grade Ⅲ and grade Ⅱ patients;the left ventricular ejection fraction(LVEF),and ratio of peak mitral flow velocity in early diastole to peak mitral flow velocity in late diastole(E/A)were lower than those in grade Ⅲ and grade Ⅱ patients;there was statistical differences(P<0.05).LVESD,LVEDD and LA in NYHA grade Ⅲ patients were higher than those in gradeⅡ patients,and LVEF and E/A were lower than those in grade Ⅱ patients.There was statistical difference(P<0.05).The QRS voltage of NYHA grade Ⅳ,Ⅲ and Ⅱ patients were(12.02±0.89),(13.34±0.71)and(14.87±0.65)mV,the QRS duration were(133.75±15.67),(125.47±17.54)and(112.86±15.54)ms,and the QTc interval were(472.65±23.65),(441.69±22.87)and(424.66±20.54)ms.The QRS voltage of NYHA grade Ⅳ and Ⅲ patients were lower than those of grade Ⅱ patients,and the QRS duration and QTc interval were longer than those of gradeⅡ patients.There was statistical difference(P<0.05).The QRS voltage of NYHA grade Ⅳ patients was lower than that of grade Ⅲ patients,and the QRS duration and QTc interval were longer than thoseof grade Ⅲ patients.There was statistical difference(P<0.05).The diagnostic accuracy of echocardiography+electrocardiogram(99.17%)was higher than that of echocardiography(96.67%)and electrocardiogram(91.67%),and there was statistical difference(P<0.05).Conclusion During the clinical diagnosis of the disease severity of patients with coronary heart disease and heart failure,the combination of echocardiography and electrocardiogram has higher diagnostic value,and is more accurate than single detection.It can timely grasp the development of the disease,and take corresponding measures to intervene in combination with the detection results to save the life and health of patients,and is worthy of widespread clinical application.

Coronary heart diseaseHeart failureEchocardiographyElectrocardiogramSeverity of diseaesDiagnostic value

李碧茜

展开 >

353100 福建省建瓯市立医院

冠心病 心力衰竭 心脏彩超 心电图 病情程度 诊断价值

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(17)